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S U M M A R Y
Background: The consequences of the spread of Leishmania parasites to the blood from lesions in patients
with cutaneous leishmaniasis are numerous. To assess the magnitude of this invasion we conducted the
present study on patients referred to the American University of Beirut Medical Center for cutaneous
leishmaniasis.
Methods: Patients referred for the management of cutaneous leishmaniasis were included in the study.
Skin and blood cultures for Leishmania were taken from these patients.
Results: One hundred sixty-two patients were proven to have cutaneous leishmaniasis by pathology; 52%
were males and 44% females (gender information was missing for 4%). Patient age ranged from 5 months
to 70 years. None of the patients had received treatment for Leishmania. We obtained parasite isolates
from 85 patients (52.5%), proven by cultures from skin and blood/blood components. Interestingly, the
parasite was isolated in the blood and blood components of 50 patients (30.9%). Isoenzyme analysis
conﬁrmed the fact that the organisms in blood and skin were the same; from the 28 isolates that were
positive in both skin and blood, eight isolates were Leishmania major and two were Leishmania tropica.
The remaining isolates, whether positive in both blood and skin or in either of these tissues, skin or blood
and its products, were Leishmania infantum sensu lato.
Conclusions: In the current study, the detection rate of parasites in the blood of patients with cutaneous
leishmaniasis was high. This illustrates the invasive characteristic of the parasite that has escaped the
skin. Testing should be considered in areas other than Lebanon, especially around the Mediterranean
basin. Whether these ﬁndings support the administration of systemic treatment for cutaneous
leishmaniasis or not needs to be conﬁrmed in larger prospective studies.
Crown Copyright  2011 Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. All rights reserved.
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Leishmania major, Leishmania tropica, and Leishmania infantum
sensu lato usually cause cutaneous leishmaniasis, but hematoge-
nous spread can occur.1,2 Several new foci have been described in
different parts of the world,3–7 but concern about its spread is
moderate since the damage is limited and superﬁcial. The
pathology of cutaneous leishmaniasis is restricted to the dermis
and the overlying epidermal layer,8–11 and this constitutes the
basis of a large number of studies that describe the body reaction
to this parasite, especially the reaction of the immune system.12–
15 Furthermore, the classiﬁcation of this disease as a dermal* Corresponding author. Tel.: +961 1 350000; fax: +961 1 744464.
E-mail address: racha@aub.edu.lb (N. Nuwayri-Salti).
1201-9712/$36.00 – see front matter . Crown Copyright  2011 Published by Elsevier 
doi:10.1016/j.ijid.2011.03.022infection or a localized event limits the evaluation of the efﬁcacy
of any treatment modality, especially as many lesions heal
spontaneously.1
People have occasionally resorted to systemic treatment of
cutaneous leishmaniasis in order to obtain better results,
particularly after failure of topical treatment. So far only sporadic
reports have described cases where the parasite has spread to the
blood stream and is circulating carried by blood leukocytes from
one organ to another.16,17 However, the general impression has
been that these cases are atypical.18,19 Included among these
unusual cases are situations in which healed scars of the Aleppo
button recurred several years later.20 The recrudescence at the scar
site was viewed as a local event, especially when the reactivation
happened in areas geographically free of leishmaniasis. In such
instances the source of the parasite was thought to be residual
organisms limited to the skin lesion.Ltd on behalf of International Society for Infectious Diseases. All rights reserved.
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in blood and the serious implications of such ﬁndings, we decided
to undertake the current study. Our objective was to evaluate the
prevalence of Leishmania parasitemia in patients with different
types of cutaneous leishmaniasis and coming from different
geographic regions inside and outside Lebanon.
2. Materials and methods
This project received approval from the Institutional Review
Board of the American University of Beirut Medical Center
(AUBMC) as part of our epidemiologic surveillance study initiated
in 1994, when the Leishmania study group was established. The
project objectives were re-approved in 2000. Patients with skin
lesions were referred to us for tissue diagnosis and histological
conﬁrmation of Leishmania. Informed consent was obtained from
all patients enrolled in this study. A detailed history was recorded
on a special form. A proforma was completed for every patient;
information collected included patient demographics, age, gender,
history of the skin lesion, and the therapeutic regimens used until
referral. We also recorded whether similar lesions were noted in
any member of the family or in any subject in the same
neighborhood.
A biopsy of the skin lesion was obtained at the dermatology
department under local anesthesia; part of this sample was
shredded to go on a biphasic culture medium and the rest was used
for histological diagnosis. Next, about 2 ml of blood were drawn
from the patient in a citrated tube. Whole blood was inoculated in
culture ﬂasks, and the rest was separated into plasma, buffy coat,
and erythrocyte layers, each of which was placed in a culture tube
with a slant of Nicole–Novy–McNeal (NNN) medium covered with
overlay and left at 24–26 8C for observation.21
We did not use centrifugation. The isolated parasites were sub-
cultured on Schneider’s Drosophila medium22 and then collected
and analyzed on starch gel for classiﬁcation by isoenzyme
electrophoresis.23,24
3. Results
Only patients who were positive for Leishmania on histology
sections were included in this study. One hundred sixty-two
patients were proven to have cutaneous leishmaniasis by
pathology, of which 52% were males and 44% were females
(gender information was missing for 4%). The number of referred
cases over the same period was around 380 cases. The patients
ranged in age between 5 months and 70 years, and their age
distribution was 1–3 years in 2%, 4–13 years in 13%, 15–20 years in
12%, and more than 20 years in 65% (information missing for 8%).
The number of skin lesions varied between one and eight. Most of
the patients (88%) had a single lesion that was mainly found (in
73% of cases) on the upper half of the body. None of the patientsFigure 1. Lesions (arrows) on the face (A) and forearm (B) to illustrate the variety in thad received treatment for Leishmania; some of them had received
antibiotic treatment for the skin lesions.
The size of the lesions, recorded as the widest diameter, ranged
from 2 mm to 8 cm. They were described as small button-like
lesions (Figure 1), sometimes excoriated or covered by a scab, with
very little reaction at the base. A complete physical examination
performed on each patient was normal, except for the skin lesions.
No data included in the proforma implied the presence of the
parasite in blood; these included the absence of fever or any
abnormalities on blood counts.
In the current study, we obtained parasite isolates from 85
patients (52.5%) proven by skin and blood cultures. A total of 62
(38.3%) positive cultures were obtained from blood and blood
products; these were equivalent to 50 patients. The yield from the
skin lesions was equally successful in 62 cases. There were several
overlap cases between blood and buffy coat (11 cases), buffy coat
and skin (eight cases), blood and plasma (one case), and also blood
and its products on the one hand and skin on the other (27 cases).
All of these ﬁndings are summarized in Figure 2. Leishmania
parasite isolation was successful in some instances only from one
tissue, to the exclusion of the rest: effectively from whole blood in
19 cases, from buffy coat in three patients, and from skin biopsies
in 36 cases.
Furthermore, the classiﬁcation by isoenzyme electrophoresis
revealed that the parasites analyzed were invariably the same in
skin and in blood in each case of the 28 patients from whom
isolates were obtained from both skin and blood. Eight isolates
were L. major and two were L. tropica. All the rest of the isolates,
whether positive in both blood and skin or in each of the two
tissues, skin or blood and its products, were L. infantum sensu lato.
4. Discussion
Leishmaniasis is endemic in more than 80 countries, with a
worldwide prevalence of 12 million.25 It occurs as a range of
syndromes that include cutaneous leishmaniasis, mucocutaneous
leishmaniasis, and visceral leishmaniasis. Cutaneous leishmaniasis
is the most common form of leishmaniasis in the Middle East.26 It
comprises skin infections caused by a single-celled parasite that is
transmitted by sandﬂy bites.27 Its annual incidence is estimated at
1–1.5 million cases.25 There are about 20 different species of
Leishmania that may cause cutaneous leishmaniasis.
The gold standard in the diagnosis of cutaneous leishmaniasis is
parasitological diagnosis. This includes histopathological exami-
nation and sometimes, when available, cultures of biopsied
sections.28 Cultures are a valuable means of allowing species
identiﬁcation, but they require some technical expertise and this
may not be readily available, and also the parasite may fail to
grow.29,30 Molecular diagnosis for cutaneous leishmaniasis has
developed greatly during the past decade.31 However, applyinghe size, appearance, and degree of inﬂammation that characterizes these patients.
Figure 2. Results of parasite cultures from the skin and the blood/blood components in patients with cutaneous leishmaniasis.
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extensive laboratory infrastructure.
The hematogenous dissemination of the parasite has been
considered responsible for the metastatic forms of cutaneous
leishmaniasis. An event observed so far only in Central and South
America, many researchers in the ﬁeld have demonstrated
metastasis by various means.21,32–34 Meanwhile several research-
ers have attempted parasite isolation from peripheral blood, but
few have been successful35 and several others have failed.21,32 We
have previously reported, on two occasions, what are considered
very unusual cases.18,19
In the current study, the detection rate of the parasite further
proven by cultures was 52.5% (85/162), which includes positive
skin cultures (62/162) and positive blood cultures in those who
were negative by skin culture (23/162) (Figure 2). On the other
hand we were able to isolate the parasite by culturing blood and
blood components at a rate of 30.9% (50/162) regardless of the skin
culture results. This detection rate is higher compared to that of
other studies, probably because other investigators have used less
sensitive methods.16,17 What is well established in our part of the
world is that rarely, if ever, has anyone observed systemic
leishmaniasis in a patient who has had the cutaneous form of
the disease. Our data may now explain why some patients have
reactivation of the skin ulcers36 or more importantly develop
visceral or mucosal disease,37 especially when the treatment for
the skin lesion was local. Furthermore, this fact favors the
recommendation that cutaneous leishmaniasis be treated system-
ically.
Our worry in these cryptic carrier cases stems from several
additional considerations. Although these people have only a
limited disease, they may be carriers of the parasite with an active
or even a healed scar (as is bound to happen with local treatment),
and may thus constitute a possible reservoir for parasite
propagation by the vector in endemic areas. It may be safer that
all precautions dictated by such a situation be taken.
In infants and young children, the cryptic parasite could depress
immunity causing frequent and varied health problems, the least
serious being repeated skin, systemic, bacterial, and viral infec-
tions (Nuwayri-Salti et al., unpublished data), even if the family
happens to then be living in a non-endemic zone.
Our suggestions are several and the ﬁrst and simplest is that
cultures of blood or its products improve the chances of conﬁrming
the diagnosis and offer a better means of identifying the parasite.
Hence a blood sample should be taken in addition to theconventional skin biopsy, especially in cases of lupoid leishmania-
sis in which demonstration of the parasite histologically in the skin
lesion invariably fails.8–11 Second, this invasiveness probably
illustrates a characteristic of the parasite that has escaped us so far,
due to the protean systemic symptoms noted by Pampiglione et al.
early on (1974).38
Finally, we hope that by alerting colleagues in this ﬁeld to this
entity, namely the presence of asymptomatic carriers after a cured
dermal leishmaniasis in endemic zones,39 this entity will be
considered more often in their differential, thus allowing better
evaluation and understanding of this entity.
To conclude, the present study constitutes an incomplete
answer to a query we recorded long ago, namely ‘‘How prevalent is
hematogenous spread of Leishmania parasites from lesions in
patients with cutaneous leishmaniasis? Is it related to the sub-
strain of parasite involved?’’ This is because in Lebanon we have
proved23 that in the majority of cases by far, the parasite strain
identiﬁed is closer to this special isolate of L. infantum sensu lato
than to the classical dermotropic strains.
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